Some patients also report hair thinning, which typically occurs after prolonged use at high dosages, and may reflect nutritional deficiencies rather than a direct pharmacologic effect, he adds
The most commonly reported side effects include: Nausea Mild stomach discomfort Constipation Diarrhea Reduced appetite These symptoms are typically mild to moderate and often occur during the early stages of treatment or when increasing the dosage
A report of nine incidences of progressive vision loss among people using semaglutide or tirzepatide, the study adds to a growing body of work examining the trend, but study investigators point out there was no way to link the use of these new agents directly to ophthalmic conditions reported
Patients will start to see the effects of Semaglutide working after the first dose and should start experiencing weight loss within the first two weeks of their program
*Correspondence: Bharathi S
Over 70% of Americans are either overweight or have obesity, so a large percentage of the target population for addiction treatment already falls into the broad category of individuals for whom GLP-1s have well studied benefits for health and mortality